/
/
/

Nureca Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020
₹40 Cr₹35 Cr₹40 Cr₹38 Cr₹34 Cr₹32 Cr₹26 Cr₹31 Cr₹20 Cr₹17 Cr₹22 Cr₹31 Cr₹21 Cr₹21 Cr₹28 Cr₹37 Cr₹26 Cr₹41 Cr₹48 Cr₹47 Cr₹119 Cr₹32 Cr₹59 Cr₹92 Cr₹30 Cr₹33 Cr
₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr₹1 Cr₹3 Cr₹6 Cr-₹1 Cr₹6 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹71 L₹66 L₹16 L₹5 L
₹42 Cr₹36 Cr₹42 Cr₹40 Cr₹37 Cr₹34 Cr₹28 Cr₹34 Cr₹26 Cr₹16 Cr₹28 Cr₹35 Cr₹24 Cr₹23 Cr₹30 Cr₹39 Cr₹27 Cr₹43 Cr₹50 Cr₹49 Cr₹122 Cr₹33 Cr₹60 Cr₹93 Cr₹30 Cr₹33 Cr
₹38 Cr₹42 Cr₹37 Cr₹35 Cr₹35 Cr₹31 Cr₹31 Cr₹34 Cr₹23 Cr₹22 Cr₹27 Cr₹31 Cr₹25 Cr₹25 Cr₹29 Cr₹42 Cr₹32 Cr₹44 Cr₹43 Cr₹41 Cr₹73 Cr₹28 Cr₹52 Cr₹56 Cr₹17 Cr₹29 Cr
₹5 Cr-₹5 Cr₹5 Cr₹6 Cr₹2 Cr₹3 Cr-₹3 Cr₹81 L₹3 Cr-₹6 Cr₹2 Cr₹5 Cr-₹23 L-₹1 Cr₹98 L-₹3 Cr-₹5 Cr-₹1 Cr₹7 Cr₹8 Cr₹49 Cr₹6 Cr₹9 Cr₹37 Cr₹13 Cr₹4 Cr
₹20 L₹30 L₹28 L₹46 L₹25 L₹62 L₹18 L₹27 L₹15 L₹18 L₹11 L₹8 L₹12 L₹10 L₹11 L₹10 L₹14 L₹29 L₹11 L₹12 L₹22 L₹38 L₹4 L₹82 L₹36 L₹38 L
₹4 Cr-₹6 Cr₹5 Cr₹5 Cr₹1 Cr₹2 Cr-₹3 Cr-₹8 L₹3 Cr-₹6 Cr₹95 L₹4 Cr-₹93 L-₹2 Cr₹27 L-₹4 Cr-₹5 Cr-₹2 Cr₹6 Cr₹8 Cr₹49 Cr₹5 Cr₹8 Cr₹36 Cr₹13 Cr₹3 Cr
₹3 Cr-₹6 Cr₹4 Cr₹4 Cr₹81 L₹2 Cr-₹3 Cr-₹48 L₹2 Cr-₹4 Cr₹17 L₹3 Cr-₹71 L-₹2 Cr₹30 L-₹3 Cr-₹4 Cr-₹1 Cr₹5 Cr₹5 Cr₹36 Cr₹4 Cr₹6 Cr₹27 Cr₹9 Cr₹2 Cr

Share Price Live Stats

Open (₹)331.90
Volume (₹)2,700.00
High (₹)331.90
Upper Circuit349.20
Low (₹)320.10
Lower Circuit316.00
Prev Close332.60
52W High (₹)358.00
Price323.00
52W Low (₹)204.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)318.70 Cr
Div. Yield (%)0.00
PE Ratio73.48
Debt to Equity0.00
Price to Book1.09
Book Value189.44
EPS (TTM)4.55
Face Value10.00
ROE (%)1.11

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
LENSKARTNSE
POLYMEDNSE
MOLBIONSE
QLINE-SMNSE
3BBLACKBIONSE
LAXMIDENTLNSE
OSELDEVICE-SMNSE
NURECA-BENSE
YASHOPTICS-SMNSE
AVIENCE-SMNSE
LTP
1W Low
1W High
Market cap (₹)
683.5+47.35 (7.44%)
640.95
694.80
1,16,821Cr
1727.6-5.4 (-0.31%)
1706.50
1858
17,930Cr
1127.9+33.15 (3.03%)
1035.20
1161.10
13,068Cr
645+96.05 (17.50%)
558
659.75
1,487Cr
1442.5+1.3 (0.09%)
1430
1588.90
1,272Cr
200.18+0.4 (0.20%)
189.45
201
1,094Cr
385-8.7 (-2.21%)
360
398.40
683Cr
323-8.05 (-2.43%)
320.10
348.35
319Cr
121+3.7 (3.15%)
119
128
300Cr
274.9+5.4 (2.00%)
264.70
281.75
148Cr

Key Highlights of Nureca Ltd’s P&L

In 2026-03-31, Nureca Ltd reported total revenue of ₹155.06Cr, compared with ₹122.37Cr in 2025-03-31, reflecting Nureca Ltd turnover.

Depreciation was ₹2.02Cr and finance costs were ₹1.28Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹4.98Cr in 2026-03-31 as compared to ₹1.34Cr in 2025-03-31.

Net Profit (PAT) was ₹2.08Cr in 2026-03-31 compared with ₹84.6Lakh in 2025-03-31.

Earnings per share (EPS) were ₹2.18 in 2026-03-31, compared with ₹0.85 in 2025-03-31.